STERIS plc (NYSE:STE) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of STERIS plc (NYSE:STE – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $243.75.

Several research analysts recently weighed in on STE shares. StockNews.com raised STERIS from a “hold” rating to a “buy” rating in a research note on Thursday, January 5th. KeyCorp reduced their target price on STERIS from $240.00 to $210.00 and set an “overweight” rating for the company in a report on Friday, November 11th.

STERIS Trading Up 0.8 %

NYSE:STE opened at $206.85 on Tuesday. STERIS has a 1 year low of $159.21 and a 1 year high of $255.93. The stock has a market cap of $20.65 billion, a price-to-earnings ratio of -1,880.28, a PEG ratio of 2.21 and a beta of 0.80. The business has a fifty day moving average of $187.07 and a 200-day moving average of $189.92. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.42 and a current ratio of 2.16.

STERIS (NYSE:STE – Get Rating) last announced its earnings results on Wednesday, November 9th. The medical equipment provider reported $1.99 earnings per share for the quarter, missing the consensus estimate of $2.00 by ($0.01). STERIS had a negative net margin of 0.17% and a positive return on equity of 12.75%. The firm had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.22 billion. During the same period in the prior year, the business earned $1.99 EPS. The company’s quarterly revenue was up .3% compared to the same quarter last year. Equities analysts predict that STERIS will post 8.44 earnings per share for the current year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 16th. Stockholders of record on Tuesday, November 22nd were issued a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 0.91%. The ex-dividend date of this dividend was Monday, November 21st. STERIS’s dividend payout ratio is -1,708.94%.

Institutional Investors Weigh In On STERIS

Hedge funds have recently bought and sold shares of the business. Sumitomo Mitsui Trust Holdings Inc. lifted its stake in STERIS by 6.3% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 431,406 shares of the medical equipment provider’s stock worth $71,734,000 after acquiring an additional 25,585 shares in the last quarter. Treasurer of the State of North Carolina lifted its stake in STERIS by 14.1% in the 2nd quarter. Treasurer of the State of North Carolina now owns 37,434 shares of the medical equipment provider’s stock worth $7,717,000 after acquiring an additional 4,622 shares in the last quarter. Kentucky Retirement Systems lifted its stake in STERIS by 16.4% in the 2nd quarter. Kentucky Retirement Systems now owns 7,431 shares of the medical equipment provider’s stock worth $1,532,000 after acquiring an additional 1,049 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its stake in STERIS by 42.0% in the 2nd quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,633 shares of the medical equipment provider’s stock worth $337,000 after acquiring an additional 483 shares in the last quarter. Finally, Guardian Capital LP lifted its stake in STERIS by 22.6% in the 2nd quarter. Guardian Capital LP now owns 9,204 shares of the medical equipment provider’s stock worth $1,897,000 after acquiring an additional 1,694 shares in the last quarter. 92.35% of the stock is owned by hedge funds and other institutional investors.

STERIS Company Profile

(Get Rating)

STERIS Plc engages in the provision of healthcare and life science product and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites.